Research Update: Banco De Bogota S.A. Y Subsidiarias Assigned 'BBB-/A-3' Global-Scale Ratings; Outlook Stable Dec 11

  • ID: 2029602
  • December 2011
  • Standard & Poors
1 of 3

Following our review of Banco de Bogota under Standard & Poor's revised bank criteria (published on Nov. 9, 2011), we are assigning our global-scale 'BBB-/A-3' issuer credit ratings on the bank. The outlook is stable. We are also assigning a 'BBB-' issue rating on the bank's $1.0 billion proposed senior unsecured notes. Banco de Bogota's ratings reflect its strong business position, moderate capital and earnings, adequate risk position, average funding, and adequate liquidity. We expect the bank to maintain moderate capitalization and fairly adequate earnings capacity. We do not expect rating changes in the next 18 months. As we previously announced, on Dec. 8, 2011, Standard & Poor's Rating Services assigned its global-scale 'BBB-' long-term and 'A-3' short-term issuer credit...

Companies mentioned in this report are: Banco de Bogota S.A. y Subsidiarias
Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Banco de Bogota S.A. y Subsidiarias

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.